Acute and Delayed Doxorubicin-Induced Myocardiotoxicity Associated with Elevation of Cardiac Biomarkers, Depletion of Cellular Antioxidant Enzymes, and Several Histopathological and Ultrastructural Changes

Doxorubicin (DOX; Adricin) is an anthracycline antibiotic, which is an efficient anticancer chemotherapeutic agent that targets many types of adult and pediatric tumors, such as breast cancer, leukemia, and lymphomas. However, use of DOX is limited due to its cardiotoxic effects. This study sequenti...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelatty, Alaa, Ahmed, Mohamed S., Abdel-Kareem, Mona A., Dmerdash, Mohamed, Mady, Rehab, Saad, Ahmed S., Albrakati, Ashraf, Elmahallawy, Ehab Kotb, Elsawak, Ahmed, Abdo, Walied
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467687/
https://www.ncbi.nlm.nih.gov/pubmed/34575029
http://dx.doi.org/10.3390/life11090880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467687/
https://www.ncbi.nlm.nih.gov/pubmed/34575029
http://dx.doi.org/10.3390/life11090880

Ejemplares similares